Valneva SE
Company Profile
Business description
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
Contact
6 Rue Alain Bombard
Saint-Herblain44800
FRAT: +33 228073710
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
713
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,768.50 | 5.10 | -0.06% |
CAC 40 | 7,557.31 | 0.85 | -0.01% |
DAX 40 | 23,649.30 | 150.97 | 0.64% |
Dow JONES (US) | 43,386.84 | 404.41 | 0.94% |
FTSE 100 | 8,735.60 | 16.85 | 0.19% |
HKSE | 24,309.68 | 15.72 | -0.06% |
NASDAQ | 20,167.91 | 194.36 | 0.97% |
Nikkei 225 | 40,155.78 | 571.20 | 1.44% |
NZX 50 Index | 12,530.32 | 50.27 | 0.40% |
S&P 500 | 6,141.02 | 48.86 | 0.80% |
S&P/ASX 200 | 8,541.10 | 9.70 | -0.11% |
SSE Composite Index | 3,441.30 | 7.15 | -0.21% |